Friday, November 8, 2019

Strides Pharma relaunches Ranitidine tablets in US

Strides Pharma relaunches Ranitidine tablets in US The company had suspended sales of its generic Ranitidine tablets after the US Food and Drug Administration (USFDA) found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA.

from Moneycontrol Business News https://ift.tt/32qJ21Z
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and...